Advertisement
Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lichtenstein, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lichtenstein, G.
American Journal of Health-System Pharmacy, Vol. 66, Issue 1, 27-37
Copyright © 2009. American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/04/0602-1242$06.00


Clinical Review

Bowel preparations for colonoscopy: A review

Gary Lichtenstein

GARY LICHTENSTEIN, M.D., is Professor of Medicine, Division of Gastroenterology, Department of Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, 3rd Floor Ravdin Building, Philadelphia, PA 19104-4283 (grl{at}uphs.upenn.edu).


Purpose. The mechanisms of action, clinical efficacy, tolerability, and safety of two major classes of bowel purgatives, poly-ethylene glycol- electrolyte lavage solutions (PEG-ELSs) and sodium phosphate preparations, are reviewed.

Summary. PEG-ELSs are osmotically balanced preparations that promote bowel cleansing through the ingestion of nonabsorbable fluid. Sodium phosphate preparations are hyperosmotic purgatives that promote bowel cleansing by osmotically drawing fluid into the bowel lumen for evacuation. Studies suggest that 2-L PEG-ELS regimens are generally as effective as and more tolerable than full-volume PEG-ELS preparations. Studies have also found that sodium phosphate tablets may provide a more tolerable alternative to PEG-ELS regimens and traditional sodium phosphate products without compromising bowel cleansing efficacy. Proper renal function plays a particularly important role in avoiding potential safety issues related to sodium phosphate-induced shifts in the fluid and electrolyte balance. Preventing dehydration in patients undergoing bowel preparation can prevent severe adverse events, regardless of the purgative administered. Optimizing the process of bowel preparation involves administering proper purgative choices in appropriate patient populations. Moreover, patient education and compliance with preparation instructions, including correct dosing and adequate hydration, may reduce the risk of adverse events and serious complications.

Conclusion. Although next -generation PEG-ELS and sodium phosphate products are well tolerated and preferred by patients over traditional bowel preparation regimens, safety issues remain a concern for both purgative classes. Sodium phosphate preparations are generally more effective and better tolerated than PEG-ELS formulations but should be administered with caution in patients with preexisting or at an increased risk for electrolyte disturbances.

Index terms: Cathartics and laxatives; Colonoscopy; Compliance; Electrolytes; Mechanism of action; Patient information; Patients; Polyethylene glycol; Sodium phosphate dibasic; Toxicity

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society of Health-System Pharmacists.
Advertisement